North American Scientific — Merger or Acquisition (October 2003)
31 slides from North American Scientific's merger presentation, Oct 28, 2003
Slide 1: Innovative radiation products for the diagnosis, management and treatment of disease
yi Innovative radiation products for the diagnosis, management and treatment of disease
Slide 2: North American Scientific to Acquire NOMOS
y, NORTH AMERICAN "A SCIENTIFIC 1 North American Scientific to Acquire NOMOS
Slide 3: Forward Looking Statements
Link to searchable text of slide shown above
Slide 4: Link to
Link to searchable text of slide shown above
Slide 5: Transaction Summary
Transaction Summary Transaction $56 million acquisition NASI Consideration 6.3 million NASI Shares + $12 million in cash NASI: 62.5% Pro Forma Ownership Nagos eres. John Friede: 18 Months EOE Bnened Other Selected Shareholders: 6-12 Months Board of Directors 7 Current NASI Directors fat clocine) 2 N
Slide 6: Transaction Rationale
Transaction Rationale = Creates a leading position in radiation therapy — Brachytherapy & External Beam hart) = Builds critical mass - products, customers, market presence = Broadens product offering for cross marketing opportunities = Diversifies NASI’s product portfolio and revenue base = Leverage
Slide 7: Privately held company based in Pennsylvania
= Privately held company based in Pennsylvania = Recognized pioneer of innovative technology = Broad radiation treatment planning suite = Large installed customer base = Strong product development team = Exceptional customer service = Strategic partnerships and international marketing presence = Str
Slide 8: Link to
Link to searchable text of slide shown above
Slide 9: NOMOS
NOMOS
Slide 10: NOMOS
NOMOS = IMRT modulates shape and intensity of radiation beam during treatment = Software and hardware to deliver a superior combination of beam intensity and angles specific to each patient and to each tumor = The ability to treat a target of any size or shape = Technology of choice for certain radi
Slide 11: IMRT Opportunity
IMRT Opportunity mu IMRT market estimated at $600 - $800 million worldwide* m Early phase of technology adoption = Strong physician support and reimbursement driving growth a IMRT centers projected to triple by = 2006 {500 to 1,500}* PB 8,000 Linear Accelerators Worldwide 400 - 500 New Linaes projec
Slide 12: Link to
Link to searchable text of slide shown above
Slide 13: Advantages of IMRT Over Conventional Radiation Therapy
Advantages of IMRT Over Conventional Radiation Therapy 3D Conventional Neck Delivery 2D Conventional Neck Delivery NOMOS IMRT Neck Delivery
Slide 14: Link to
Link to searchable text of slide shown above
Slide 15: Link to
Link to searchable text of slide shown above
Slide 16: Innovative Products
Innovative Products ore NC
Slide 17: PEACOCK (CORVUS and MIMiC)
PEACOCK (CORVUS and MIMiC) Complete IMRT treatment planning and delivery — Inverse treatment planning system (software and MLC) — Determines true “optimized” treatment plan — Delivers superior beam coverage — Easy integration with most linear accelerators — Supports stereotactic radiosurgery CORVUS
Slide 18: BAT
BAT Image-guided (ultrasound) patient positioning — “Gold Standard’ for non-invasive targeting — First targeting technology of its kind — Enables safer dose escalation — Proven clinical advantages BAT SXi with Breakthrough| ImageSync — Compatible with all major systems Increased Accuracy Improves Tu
Slide 19: PEREGRINE
PEREGRINE Monte Carlo-based dose calculation — Calculates dose distribution “before” treatment — Only FDA approved system of its kind — Highly accurate (to within 2% RSM or 2mm) — Fast (hundreds of millions of simulations in minutes) Provides Predictable Dose Outcome Prior to Treatment NORTH AMERICA
Slide 20: NOMOS Rx
NOMOS Rx Remote treatment planning service that makes IMRT feasible for any facility — Easy to implement IMRT — Provides in-depth training, verification and quality assurance — Tailored to each clinic — Reduces equipment costs and staff time Facilitates easy and rapid IMRT adoption NORTH AMERICAN SC
Slide 21: Competitive Landscape
Competitive Landscape Key Product Areas IMRT planning IMRT delivery Non-invasive target localization Monte Carlo dose calc Remote treatment planning
Slide 22: NASI / NOMOS Creating Shareholder Value
NASI / NOMOS Creating Shareholder Value
Slide 23: NASI... Creating Value
NASI... Creating Value m Revenue and earnings growth m Free cash flow = Product portfolio diversification = International expansion Wm, NORTH AMERICAN “44 SCIENTIFIC
Slide 24: Link to
Link to searchable text of slide shown above
Slide 25: Link to
Link to searchable text of slide shown above
Slide 26: Link to
Link to searchable text of slide shown above
Slide 27: Link to
Link to searchable text of slide shown above
Slide 28: Link to
Link to searchable text of slide shown above
Slide 29: Link to
Link to searchable text of slide shown above
Slide 30: Summary... NASI Creating Value
Summary... NASI Creating Value = Leadership in larger radiation therapy market (Brachytherapy and External Beam) m Significant revenue growth = Positive free cash flow m Increased liquidity m Upsides with synergies and new product development “ mm NORTH AMERICAN
Slide 31: Searchable text section of graphics
Searchable text section of graphics shown above [LOGO] [GRAPHIC] Innovative radiation products for the diagnosis, management and treatment of disease [GRAPHIC] North American Scientific to Acquire NOMOS Forward Looking Statements Statements throughout today’s presentation that are not historical fac
North American Scientific — Merger or Acquisition (October 2003) on 6ix